DOW JONES27,960.80+0.00 0.00%
S&P 5003,225.89+0.00 0.00%
NASDAQ9,221.28+0.00 0.00%

Gabelli & Co. Downgrades Lexicon Pharmaceuticals to Hold

Gabelli & Co. analyst Kevin Kedra downgrades Lexicon Pharmaceuticals (NASDAQ:LXRX) from Buy to Hold.

Benzinga · 12/11/2019 13:35

Gabelli & Co. analyst Kevin Kedra downgrades Lexicon Pharmaceuticals (NASDAQ:LXRX) from Buy to Hold.